These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25723084)

  • 1. The 4G/4G polymorphism of the plasminogen activator inhibitor-1 (PAI-1) gene as an independent risk factor for placental insufficiency, which triggers fetal hemodynamic centralization.
    Souza PC; Alves JA; Maia SM; Araujo Júnior E; Santana EF; Silva Costa FD
    Ceska Gynekol; 2015 Jan; 80(1):74-9. PubMed ID: 25723084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications.
    Glueck CJ; Phillips H; Cameron D; Wang P; Fontaine RN; Moore SK; Sieve-Smith L; Tracy T
    Metabolism; 2000 Jul; 49(7):845-52. PubMed ID: 10909993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual vein thrombosis and onset of post-thrombotic syndrome: influence of the 4G/5G polymorphism of plasminogen activator inhibitor-1 gene.
    Incalcaterra E; Meli F; Muratori I; Corrado E; Amato C; Canino B; Ferrara F
    Thromb Res; 2014 Mar; 133(3):371-4. PubMed ID: 24485402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study.
    Prabhudesai A; Shetty S; Ghosh K; Kulkarni B
    Eur J Haematol; 2017 Sep; 99(3):249-254. PubMed ID: 28561456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I plasminogen activator inhibitor 4G allele frequency is associated with chronic venous insufficiency.
    Katrancioglu N; Manduz S; Ozen F; Yilmaz MB; Karahan O; Ozdemir O; Berkan O
    J Int Med Res; 2010; 38(4):1513-8. PubMed ID: 20926026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts.
    Wiklund PG; Nilsson L; Ardnor SN; Eriksson P; Johansson L; Stegmayr B; Hamsten A; Holmberg D; Asplund K
    Stroke; 2005 Aug; 36(8):1661-5. PubMed ID: 16020771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
    Deng A; Gocke CD; Hess J; Heyman M; Paltiel M; Gaspari A
    Arch Dermatol; 2006 Nov; 142(11):1466-9. PubMed ID: 17116837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss.
    Magdoud K; Herbepin VG; Touraine R; Almawi WY; Mahjoub T
    Am J Reprod Immunol; 2013 Sep; 70(3):246-52. PubMed ID: 23521508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between the 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and the pathogenesis of pregnancy-induced hypertension syndrome].
    Guan LX; Du XY; Wang JX; Wang RL; Wu ZL; Jiang H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):173-5. PubMed ID: 15079805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
    Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association of genetic polymorphisms in plasminogen activator inhibitor-1 gene and 5,10-methylenetetrahydrofolate reductase gene with recurrent early spontaneous abortion].
    Guan LX; Du XY; Wang JX; Gao L; Wang RL; Li HB; Wang SX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):330-3. PubMed ID: 15952129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia.
    Yamada N; Arinami T; Yamakawa-Kobayashi K; Watanabe H; Sohda S; Hamada H; Kubo T; Hamaguchi H
    J Hum Genet; 2000; 45(3):138-41. PubMed ID: 10807538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome.
    Tàssies D; Espinosa G; Muñoz-Rodríguez FJ; Freire C; Cervera R; Monteagudo J; Maragall S; Escolar G; Ingelmo M; Ordinas A; Font J; Reverter JC
    Arthritis Rheum; 2000 Oct; 43(10):2349-58. PubMed ID: 11037896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome].
    Reshetniak TM; Ostriakova EV; Patrusheva NL; Patrushev LI; Aleksandrova EN; Seredavkina NV; Volkov AV; Nasonov EL
    Ter Arkh; 2013; 85(1):76-84. PubMed ID: 23536951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between plasminogen activator inhibitor-1 4G/5G polymorphism and pre-eclampsia: an appraisal.
    Wiwanitkit V
    Arch Gynecol Obstet; 2006 Mar; 273(6):322-4. PubMed ID: 16502012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency.
    Zöller B; García de Frutos P; Dahlbäck B
    Thromb Haemost; 1998 Apr; 79(4):802-7. PubMed ID: 9569196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome.
    Glueck CJ; Sieve L; Zhu B; Wang P
    Metabolism; 2006 Mar; 55(3):345-52. PubMed ID: 16483878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitor-1 activity and 4G/5G polymorphism in hemodialysis.
    Trimarchi H; Duboscq C; Genoud V; Lombi F; Muryan A; Young P; Schwab M; Castanon M; Rodriguez-Reimundes E; Forrester M; Pereyra H; Campolo-Girard V; Seminario O; Alonso M; Kordich L
    J Vasc Access; 2008; 9(2):142-7. PubMed ID: 18609532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis.
    Akhter MS; Biswas A; Ranjan R; Meena A; Yadav BK; Sharma A; Saxena R
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):184-8. PubMed ID: 19419975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.